Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 23-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 52)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
20-Nov-09New Constructs, LLCN/AILMN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ILLUMINA -- ILMN1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ELGX , HCCI , ILMN , OCLS , RMTI -- MEDICAL SUPPLIES & EQUIPMENT3$4  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
18-Nov-09Rapid RatingsRapid RatingsILLUMINA INC rated hold (2009-11-18) (US$665)8$665  View Abstract
17-Nov-09Zacks Investment Research Inc.N/AILLUMINA INC (ILMN) Zacks Company Snapshot1$10  View Abstract
15-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169  View Abstract
15-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169  View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ILLUMINA INC5$25  View Abstract
Next 20

Brokerage Reports (Showing 1 to 6 of 6)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
5-Nov-09Caris & CompanyZarak KhurshidILMN-Broad Institute Purchases 30 More Sequencers7$254 Stars 4 Stars View Abstract
28-Oct-09Caris & CompanyZarak KhurshidILMN- Upgrading from 3/Average to 2/Above Average9$254 Stars 4 Stars View Abstract
28-Oct-09Thomson StreetEventsN/AILMN - Event Transcript of Illumina, Inc. conference call, Oct. 27, 2009 / 5:00pm ET20$75  View Abstract
28-Oct-09Thomson StreetEventsN/AILMN - Event Brief of Illumina, Inc. conference call, Oct. 27, 2009 / 5:00pm ET21$75  View Abstract
26-Oct-09Caris & CompanyZarak KhurshidILMN-Expecting In-line 3Q09 Financials6$254 Stars 4 Stars View Abstract
30-Mar-09First GlobalLe Grand FromagFirst Global's Le Grand Fromage: Eats shoots and leaves6$30  View Abstract

Independent Reports (Showing 1 to 10 of 46)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
20-Nov-09New Constructs, LLCN/AILMN: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: ILLUMINA -- ILMN1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ELGX , HCCI , ILMN , OCLS , RMTI -- MEDICAL SUPPLIES & EQUIPMENT3$4View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
19-Nov-09Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
18-Nov-09Rapid RatingsRapid RatingsILLUMINA INC rated hold (2009-11-18) (US$665)8$665View Abstract
17-Nov-09Zacks Investment Research Inc.N/AILLUMINA INC (ILMN) Zacks Company Snapshot1$10View Abstract
15-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)103$169View Abstract
15-Nov-09Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)101$169View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: ILLUMINA INC5$25View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.